Brain training app reduces symptoms of pre-dementia
July 5, 2017App improves episodic memory by 40%.
X
Brain training app reduces symptoms of pre-dementia
https://pharmaphorum.com/news/brain-training-dementia/
neurology
Alder shares slump despite migraine success
June 28, 2017Investors concerned over strong placebo effect
UK patients gain early access to Duchenne drug
June 26, 2017Patients to get Santhera’s Raxone under EAMS scheme.
Shire long-acting ADHD drug finally approved
June 21, 2017Mydadis approval ends decade-long saga with FDA.
Novartis files migraine drug with EMA
June 21, 2017Erenumab could be first new treatment in a decade.
LifeArc spends Keytruda cash on R&D ignored by pharma
June 15, 2017Formerly known as MRC Technology, charity to spend Keytruda royalties on R&D considered too risky by big pharma
Teva plans migraine drug filing later this year
June 8, 2017Blockbuster hopeful could launch next year if approved.
AZ sells migraine drug rights to Grunenthal for $300m
June 7, 2017AZ says migraine outside its strategic focus.
